{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "62856-405",
      "generic_name": "lemborexant",
      "labeler_name": "Eisai Inc.",
      "dea_schedule": "CIV",
      "brand_name": "DAYVIGO",
      "active_ingredients": [
        {
          "name": "LEMBOREXANT",
          "strength": "5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "62856-405-10",
          "description": "1 BLISTER PACK in 1 CARTON (62856-405-10)  / 10 TABLET, FILM COATED in 1 BLISTER PACK",
          "marketing_start_date": "20200407",
          "sample": true
        },
        {
          "package_ndc": "62856-405-30",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (62856-405-30)",
          "marketing_start_date": "20200407",
          "sample": false
        },
        {
          "package_ndc": "62856-405-90",
          "description": "90 TABLET, FILM COATED in 1 BOTTLE (62856-405-90)",
          "marketing_start_date": "20200407",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Eisai Inc."
        ],
        "rxcui": [
          "2272408",
          "2272414",
          "2288425",
          "2288427"
        ],
        "spl_set_id": [
          "7074cb65-77b3-45d2-8e8d-da8dc0f70bfd"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0362856410304",
          "0362856405300",
          "0362856410908",
          "0362856405904"
        ],
        "nui": [
          "N0000191000",
          "N0000190998",
          "N0000187064"
        ],
        "pharm_class_epc": [
          "Orexin Receptor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Orexin Receptor Antagonists [MoA]",
          "Cytochrome P450 2B6 Inducers [MoA]"
        ],
        "unii": [
          "0K5743G68X"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "c82838dc-6934-4541-8a02-bd44ee5bb82a",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20200407",
      "product_id": "62856-405_c82838dc-6934-4541-8a02-bd44ee5bb82a",
      "application_number": "NDA212028",
      "brand_name_base": "DAYVIGO",
      "pharm_class": [
        "Cytochrome P450 2B6 Inducers [MoA]",
        "Orexin Receptor Antagonist [EPC]",
        "Orexin Receptor Antagonists [MoA]"
      ]
    }
  ]
}